Role of peri-operative intravenous lidocaine infusion in postoperative pain and recovery following laparoscopic renal surgeries.

Role of peri-operative intravenous lidocaine infusion in postoperative pain and recovery following laparoscopic renal surgeries: A randomised control trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/10/015912

Enrollment

Registered

2018-10-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N998- Other intraoperative and postprocedural complications and disorders of genitourinary system Health Condition 2: N998- Other intraoperative and postprocedural complications and disorders of genitourinary system

Interventions

Intervention1: lidocaine 2% preservative free with placebo control.: Intravenous Lignocaine 2 % infusion will be started 30 minutes before skin incision and continue it till sugery is over. Intravenou

Eligibility

Inclusion criteria

Inclusion criteria: 1.American Society of Anesthesiologists (ASA) physical status I-III, 2.Undergoing laparoscopic renal surgeries under general anesthesia

Exclusion criteria

Exclusion criteria: 1.Allergic to local anesthetics 2.Patients with severe underlying cardiovascular disease, 3.Impaired kidney or liver function, 4.History of drug or alcohol abuse, 5.History of chronic pain or daily intake of analgesics, 6.Uncontrolled medical disease (diabetes mellitus and hypertension), 7.History of intake of non-steroidal anti-inflammatory drugs within 24 hours before surgery, 8.Patients with a history of psychiatric disorder, arrhythmia or seizures. 9.Nephrectomy for renal transplantation 10.Morbid obesity (BMI > 40)

Design outcomes

Primary

Measure	Time frame
The primary outcome are the requirement of inhalational agent, postoperative pain intensity and bowel function.Timepoint: Patient will observed till discharged from the hospital.	—

Secondary

Measure	Time frame
Patient comfort and total hospital stayTimepoint: first followup	—

Countries

India

Contacts

Public ContactDR DINESH J PRAJAPATI

MULJIBHAI PATEL UROLOGICAL HOSPITAL,

dr_djp2011@hotmail.com9879399866

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026